Your new post is loading...
The project "EXOpro: Development of a scalable manufacturing process for therapeutic human mesenchymal stem/stromal cell-derived exosomes" has been recommended for funding by FCT. The goal of EXOpro is to develop a fully controlled manufacturing process for the production and purification of an effective, safe and fully characterized MSC-derived exosome-based product. Overall, the success of this project is expected to contribute to the development of novel cell-free strategies for Regenerative Medicine settings. The project, which falls within the scientific area of Chemical Engineering, is headed by Ana Fernandes from SCERG-iBB and Ana Azevedo from BERG-iBB and involves a collaboration with the University of São Paulo.
Photo details: GFP-expressing MSCs by Joana Serra, copyright iBB 2017.
